Form 4 for LFMD LifeMD, Inc.
Accepted 2023-06-16 00:00:00 ET · period of report 2023-06-15 · accession 0001362118-23-000044 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-16 | 2023-06-15 | LFMD | Yecies Eric Harold | GC, CCO | A - Grant | — | +150.0K | 212.5K | +240% | — |
| D | 2023-06-16 | 2023-06-15 | LFMD | Yecies Eric Harold | GC, CCO | D - Sale to Iss | — | -200.0K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-15 | A | A | 150,000 | — | 212,500 | D | — | — | (F1) The options are being cancelled in exchange for 150,000 restricted shares with 12,500 vesting on June 15, 2023, 37,500 shares on November 20, 2023 and 100,000 shares on January 1, 2024 and performance shares to be reported on settlement. The options vested and became exercisable in equal monthly tranches, based on the passage of time, over the 36 months following November 20, 2020. |
| 2 | Derivative | Employee Stock Option (Right to Buy) | 2023-06-15 | D | D | 200,000 | — | 0 | D | $7.55 · — to — | 200,000 Common Stock | (F1) The options are being cancelled in exchange for 150,000 restricted shares with 12,500 vesting on June 15, 2023, 37,500 shares on November 20, 2023 and 100,000 shares on January 1, 2024 and performance shares to be reported on settlement. The options vested and became exercisable in equal monthly tranches, based on the passage of time, over the 36 months following November 20, 2020. |